| Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128) |
|---|
| 05/05/1993 | EP0539627A1 A process for the purification of commercial carrageenins |
| 05/05/1993 | EP0539457A1 Compositions based on active principles of hydrophobic medicaments solubilizable in an aqueous solvent |
| 05/05/1993 | EP0539442A1 Enzyme inactivators |
| 05/05/1993 | EP0486526A4 Tumour necrosis factor binding ligands |
| 05/05/1993 | CN1020458C Conjugates of superoxide dismutase couples tod high molecular weight polyalkylene glycols |
| 05/04/1993 | US5208323 Coupling of an anti-tumor to an antibody using glutaraldehyde preactivated anti-tumor agent |
| 05/04/1993 | US5208261 Methionine and tricyclic nitrogen heterocycle antidepressants |
| 05/04/1993 | US5208256 Treatment of ocular hypertension with a synergistic combination for ocular administration |
| 05/04/1993 | US5208037 Dosage forms comprising polymers comprising different molecular weights |
| 05/04/1993 | US5208036 Complexing a liposomal composition with a quaternary ammonium diether |
| 05/04/1993 | US5208035 Water Soluble Polymer Base, Penetration Enhancing Agent |
| 05/04/1993 | US5208028 Gelled emulsion particles and compositions in which they are present |
| 05/04/1993 | US5208021 Method of preparing diphtheria immunotoxins |
| 05/04/1993 | US5208020 Cytotoxic agents comprising maytansinoids and their therapeutic use |
| 05/04/1993 | CA1317287C Cross-linked esters of hyaluronic acid |
| 05/04/1993 | CA1317230C Aqueous preparation of 9-methyl-3-(1h-tetrazol-5-yl)- 4h-pyrido ¬1,2-a|pyrimidin-4-one potassium salt |
| 04/29/1993 | WO1993008290A1 Enhanced immunogenicity using leukotoxin chimeras |
| 04/29/1993 | WO1993008273A1 Thymidine phosphorylase for use in the modulation of cellular proliferation or chemotaxis |
| 04/29/1993 | WO1993008210A1 Vascular permeability factor targeted compounds |
| 04/29/1993 | WO1993008209A1 Diagnosis and treatment of bacterial dysentery |
| 04/29/1993 | WO1993008207A1 Novel cytokine |
| 04/29/1993 | WO1993008202A1 Formation of stable liposomes from lipid extracts of archaeobacteria (archaea) |
| 04/29/1993 | WO1993007905A2 Treated apatite particles for medical diagnostic imaging |
| 04/29/1993 | WO1993007904A1 Lipophilic oligosaccharide antibiotic salt compositions |
| 04/29/1993 | WO1993007903A1 Enhanced skin penetration system for improved topical delivery of drugs |
| 04/29/1993 | WO1993007902A1 Enhanced skin penetration system for improved topical delivery of drugs |
| 04/29/1993 | WO1993007901A1 Composition for topical application |
| 04/29/1993 | WO1993007875A1 Use of prostacyclin derivatives to prevent or treat disorders of the microcirculating system when x-ray, nmr or ultrasonic contrasting agents are administered |
| 04/29/1993 | WO1993007874A1 Medicament composition for topical application |
| 04/29/1993 | WO1993007870A1 Device for the transdermal administration of melatonin |
| 04/29/1993 | WO1993007862A1 Ionic beads useful for controlled release and adsorption |
| 04/29/1993 | WO1993007861A1 Preparation and uses of multi-phase microspheres |
| 04/29/1993 | WO1993007860A1 New drug formulations with ion-exchangers |
| 04/29/1993 | WO1993007857A1 Stabilized calorific nutrient solution and multi-chamber system for the parenteral feeding of humans |
| 04/29/1993 | WO1993007856A1 LOW pH AQUEOUS COSMETIC GEL CONTAINING NON-IONIC POLYACRYLAMIDE DERIVATIVES |
| 04/29/1993 | WO1993007747A1 Antimicrobial dialdehyde composition and methods of use |
| 04/29/1993 | CA2122034A1 New drug formulations with ion-exchangers |
| 04/29/1993 | CA2121838A1 Use of prostacyclin derivatives to prevent or treat disorders of the microcirculating system when x-ray, nmr or ultrasonic contrasting agents are administered |
| 04/29/1993 | CA2121687A1 Ionic beads useful for controlled release and adsorption |
| 04/29/1993 | CA2121676A1 A stabilized caloric nutrient solution and a multicompartmental system or multiple recipient for human parenteral nourishing |
| 04/29/1993 | CA2120927A1 Enhanced skin penetration system for improved topical delivery of drugs |
| 04/29/1993 | CA2120130A1 Treated apatite particles for medical diagnostic imaging |
| 04/29/1993 | CA2116036A1 Device for the transdermal administration of melatonin |
| 04/28/1993 | EP0539319A2 Pharmaceutical cyclosporin composition |
| 04/28/1993 | EP0539215A1 Penetration enhancement of topically applied formulations |
| 04/28/1993 | EP0539167A2 Peg imidates and protein derivatives thereof |
| 04/28/1993 | EP0539140A1 Lyophilized acidic fibroblast growth factor |
| 04/28/1993 | EP0539087A1 Stabilized topical acidic fibroblast growth factor formulation |
| 04/28/1993 | EP0539059A1 Buoyant controlled release powder formulation |
| 04/28/1993 | EP0538858A1 Improved lyophilized ifosfamide compositions |
| 04/28/1993 | EP0538764A1 N-long chain acyl neutral amino acid esters; and cosmetics and pharmaceutical preparation containing the same |
| 04/28/1993 | EP0538313A1 Topical ophthalmic suspensions |
| 04/28/1993 | EP0538268A1 Targeted protection from cytotoxins |
| 04/28/1993 | EP0538267A1 MONOCLONAL ANTI-IgM ANTIBODIES, THEIR PRODUCTION AND USE, AND HYBRIDOMAS FOR PRODUCING THE SAME |
| 04/28/1993 | EP0533799A4 Compositions and methods for the controlled release of soluble active substances |
| 04/28/1993 | EP0527946A4 Controlled release vehicle |
| 04/28/1993 | EP0485530A4 Tgf--g(b) protein compositions for inhibition of cell proliferation |
| 04/28/1993 | EP0483213A4 Transdermal administration of lisuride |
| 04/28/1993 | EP0453525B1 Method of producing aqueous mixed-micelle solutions |
| 04/28/1993 | CN1071457A Conjugates for introducing nucleic acid into higher eucaryotic cells |
| 04/28/1993 | CN1071334A Solid for mulation containing amide derivative and process for preparing same |
| 04/27/1993 | US5206370 Certain pyridyl hydrazines and hydrazides useful for protein labeling |
| 04/27/1993 | US5206352 Compositions for clones containing DNA sequences associated with multidrug resistance in human cells |
| 04/27/1993 | US5206344 Using polyethylene glycol |
| 04/27/1993 | US5206267 Suspension of butyl aminobenzoate; sterility; stability; nontoxic; polyethylene glycol suspending agent; wetting agent; for subcutaneous injection |
| 04/27/1993 | US5206156 Lactoperoxidase bonded to carrier of hydrophilic saccharide with lipid and phospholipid layers, oxygen donor, oxidizable substrate; food and medical uses |
| 04/27/1993 | US5206025 Inclusion compound of active substrance and cyclodextrin, and either diluent or binder |
| 04/27/1993 | US5206023 Method and compositions for the treatment and repair of defects or lesions in cartilage |
| 04/27/1993 | US5206022 Insect repellent compositions |
| 04/27/1993 | US5206019 Soap compositions containing liquid-loaded powders |
| 04/27/1993 | CA1316829C Therapeutic composition containing sucrose fatty acid ester |
| 04/27/1993 | CA1316826C Binder-free granules with delayed release of the active compound |
| 04/27/1993 | CA1316825C Penetration enhancement systems |
| 04/27/1993 | CA1316823C Facilitation of certain drugs for capsulation |
| 04/26/1993 | CA2081248A1 Novel saccharide-based matrix |
| 04/24/1993 | CA2081061A1 Improved lyophilized ifosfamide compositions |
| 04/22/1993 | CA2080891A1 Peg imidates and protein derivatives thereof |
| 04/22/1993 | CA2080538A1 Lyophilized acidic fibroblast growth factor |
| 04/22/1993 | CA2080537A1 Stabilized topical acidic fibroblast growth factor formulation |
| 04/21/1993 | EP0538230A1 Method for producing synthetic N-linked glycoconjugates |
| 04/21/1993 | EP0538011A1 Lipophilic oligosaccharide antibiotic salt compositions |
| 04/21/1993 | EP0537998A1 Controlled release drug delivery device comprising a polymer matrix and a plasticizer |
| 04/21/1993 | EP0537559A1 Polymeric compositions useful as controlled release implants |
| 04/21/1993 | EP0537276A1 Cancer-associated scm-recognition factor, preparation and method of use |
| 04/21/1993 | EP0537229A1 Receptor directed-toxin conjugates |
| 04/21/1993 | EP0537222A1 Immunoreactive compound |
| 04/21/1993 | EP0537165A1 Polymeric drug delivery system |
| 04/21/1993 | EP0537139A1 Process for producing pressed, moulded, delayed release dose units and dose units thus produced. |
| 04/21/1993 | EP0407401B1 Human relaxin formulation |
| 04/21/1993 | EP0303683B1 Amphotericin b/cholesterol sulfate composition and method |
| 04/20/1993 | US5204449 Carriers; drug delivery; veterinary medicine; target specificity; antifertility agents; animal growth regulators monoclonal antibodies; vaccines |
| 04/20/1993 | US5204375 Betaine surface active agent having an estolide hydrophobic group |
| 04/20/1993 | US5204339 Penetration enhancers for transdermal delivery of systemic agents |
| 04/20/1993 | US5204335 Ifosfamide lyophilisate and process for its preparation |
| 04/20/1993 | US5204137 Orange flour from entire tuber, comminuted to microsize; ice cream, baby formula, fried and baked products; wheat substitute |
| 04/20/1993 | US5204121 Active material core, double layer comprising outer acrylic layer and inner jacket of hydrophobic additive and hydroxy-propyl cellulose |
| 04/20/1993 | US5204119 External preparation comprising calcium silicate |
| 04/20/1993 | US5204115 Granules with a non-cariogenic binder |
| 04/20/1993 | US5204114 Using crystalline ascorbic acid as an antistatic agent |
| 04/20/1993 | US5204107 Bound to deacetylated chitin; side effect reduction; sustained release over several months |